249 related articles for article (PubMed ID: 38305992)
1. Ovarian Suppression: Early Menopause, Late Effects.
Goldberg C; Greenberg MR; Noveihed A; Agrawal L; Omene C; Toppmeyer D; George MA
Curr Oncol Rep; 2024 May; 26(5):427-438. PubMed ID: 38305992
[TBL] [Abstract][Full Text] [Related]
2. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
3. Ovarian Insufficiency: Clinical Spectrum and Management Challenges.
Stuenkel CA
J Womens Health (Larchmt); 2024 Apr; 33(4):397-406. PubMed ID: 38190309
[TBL] [Abstract][Full Text] [Related]
4. Perils of prolonged ovarian suppression and hypoestrogenism in the treatment of breast cancer: Is the risk of treatment worse than the risk of recurrence?
Kauffman RP; Young C; Castracane VD
Mol Cell Endocrinol; 2021 Apr; 525():111181. PubMed ID: 33529690
[TBL] [Abstract][Full Text] [Related]
5. Premature ovarian insufficiency, early menopause, and induced menopause.
Hamoda H; Sharma A
Best Pract Res Clin Endocrinol Metab; 2024 Jan; 38(1):101823. PubMed ID: 37802711
[TBL] [Abstract][Full Text] [Related]
6. Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.
Nourmoussavi M; Pansegrau G; Popesku J; Hammond GL; Kwon JS; Carey MS
Cancer Treat Rev; 2017 Apr; 55():26-35. PubMed ID: 28288389
[TBL] [Abstract][Full Text] [Related]
7. Significance of Ovarian Function Suppression in Endocrine Therapy for Breast Cancer in Pre-Menopausal Women.
Scharl A; Salterberg A
Geburtshilfe Frauenheilkd; 2016 May; 76(5):516-524. PubMed ID: 27239060
[TBL] [Abstract][Full Text] [Related]
8. The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency.
Hamoda H;
Post Reprod Health; 2017 Mar; 23(1):22-35. PubMed ID: 28381102
[No Abstract] [Full Text] [Related]
9. The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical.
Acosta JI; Mayer LP; Braden BB; Nonnenmacher S; Mennenga SE; Bimonte-Nelson HA
Endocrinology; 2010 Aug; 151(8):3795-804. PubMed ID: 20555031
[TBL] [Abstract][Full Text] [Related]
10. Early menopause: primary ovarian insufficiency and surgical menopause.
Kodaman PH
Semin Reprod Med; 2010 Sep; 28(5):360-9. PubMed ID: 20845236
[TBL] [Abstract][Full Text] [Related]
11. Managing Menopause by Combining Evidence With Clinical Judgment.
Flores VA; Pal L
Clin Obstet Gynecol; 2018 Sep; 61(3):496-507. PubMed ID: 29985172
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
Bernhard J; Luo W; Ribi K; Colleoni M; Burstein HJ; Tondini C; Pinotti G; Spazzapan S; Ruhstaller T; Puglisi F; Pavesi L; Parmar V; Regan MM; Pagani O; Fleming GF; Francis PA; Price KN; Coates AS; Gelber RD; Goldhirsch A; Walley BA
Lancet Oncol; 2015 Jul; 16(7):848-58. PubMed ID: 26092816
[TBL] [Abstract][Full Text] [Related]
13. Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy.
Stuursma A; van Driel CMG; Wessels NJ; de Bock GH; Mourits MJE
Maturitas; 2018 May; 111():69-76. PubMed ID: 29673834
[TBL] [Abstract][Full Text] [Related]
14. Premature ovarian insufficiency: the context of long-term effects.
Podfigurna-Stopa A; Czyzyk A; Grymowicz M; Smolarczyk R; Katulski K; Czajkowski K; Meczekalski B
J Endocrinol Invest; 2016 Sep; 39(9):983-90. PubMed ID: 27091671
[TBL] [Abstract][Full Text] [Related]
15. OFS plus AI or SERM vs. SERM alone in premenopausal women with hormone receptor-positive breast cancer: a prospective cohort study using the real-world database.
Hu K; He P; Peng Q; Zhong X; Deng L; Xie Y; Li J; Xu H; Lu D; Zheng H
Breast Cancer; 2019 May; 26(3):339-348. PubMed ID: 30367358
[TBL] [Abstract][Full Text] [Related]
16. Potential adverse impact of ovariectomy on physical and psychological function of younger women with breast cancer.
Sayakhot P; Vincent A; Deeks A; Teede H
Menopause; 2011 Jul; 18(7):786-93. PubMed ID: 21407138
[TBL] [Abstract][Full Text] [Related]
17. Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial.
Gaba F; Robbani S; Singh N; McCluggage WG; Wilkinson N; Ganesan R; Bryson G; Rowlands G; Tyson C; Arora R; Saridogan E; Hanson H; Burnell M; Legood R; Evans DG; Menon U; Manchanda R;
Int J Gynecol Cancer; 2021 Feb; 31(2):286-291. PubMed ID: 32907814
[TBL] [Abstract][Full Text] [Related]
18. Impact of a premature menopause on cognitive function in later life.
Ryan J; Scali J; Carrière I; Amieva H; Rouaud O; Berr C; Ritchie K; Ancelin ML
BJOG; 2014 Dec; 121(13):1729-39. PubMed ID: 24802975
[TBL] [Abstract][Full Text] [Related]
19. Management of Early Menopause/Premature Ovarian Insufficiency in Women with or at High Risk of Breast Cancer.
Brennan A; Hickey M
Semin Reprod Med; 2020 Sep; 38(4-05):309-314. PubMed ID: 33791998
[TBL] [Abstract][Full Text] [Related]
20. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
Benshushan A; Rojansky N; Chaviv M; Arbel-Alon S; Benmeir A; Imbar T; Brzezinski A
Climacteric; 2009 Oct; 12(5):404-9. PubMed ID: 19479488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
